Therapeutic Efficacy of Intravenous Prostaglandin E1 Versus Pentoxifylline in Patients with Intermittent Claudication

As a rule, walking training is undoubtedly the treatment of choice for patients with arterial occlusive disease at the intermittent claudication stage (stage IIb). The adaptation of the cardiovascular and nervous system and of skeletal muscle induced by walking training increases the endurance of these patients [3]. Drug treatment is considered for patients who are not suitable candidates for, or who do not show an adequate response to, programmed exercising.